- Entry
- $3.41
- Final
- $3.02 -11.4%
- Target
- —
- Score
- -1.00
Eledone Pharmaceuticals (ELDN) just announced this study where 100% of people achieved insulin independence. It was only 12 patients but still the best result possible. Next step is probably a bigger study but could be a very good investment opportunity as the market capitalization is only $270 million. I feel like it has a ton of room to run and could be a buyout target.
— ORIGINAL POST ·
Potential Type 1 Diabetes Cure
· r/wallstreetbets
· Jun 8, 2026